Bone mineral density derived from cardiac CT scans: Using contrast enhanced scans for opportunistic screening

IF 1.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM
Andia Cheneymann , Josephine Therkildsen , Simon Winther , Louise Nissen , Jesper Thygesen , Bente L. Langdahl , Ellen-Margrethe Hauge , Morten Bøttcher
{"title":"Bone mineral density derived from cardiac CT scans: Using contrast enhanced scans for opportunistic screening","authors":"Andia Cheneymann ,&nbsp;Josephine Therkildsen ,&nbsp;Simon Winther ,&nbsp;Louise Nissen ,&nbsp;Jesper Thygesen ,&nbsp;Bente L. Langdahl ,&nbsp;Ellen-Margrethe Hauge ,&nbsp;Morten Bøttcher","doi":"10.1016/j.jocd.2023.101441","DOIUrl":null,"url":null,"abstract":"<div><p><em>Purpose</em><span><span>: Osteoporosis is under-diagnosed and often co-exists with other diseases. Very low bone mineral density (BMD) indicates risk of osteoporosis and opportunistic screening for low BMD in CT-scans has been suggested. In a non-contrast enhanced thoracic CT scan, the scan-field-of-view includes </span>vertebrae enabling BMD estimation. However, many CT scans are obtained by administration of contrast material. If the impact of contrast enhancement on BMD measurements could be quantified, considerably more patients are eligible for screening. </span><em>Methods</em>: This study investigated the impact of intravenous contrast on thoracic BMD measurements in cardiac CT scans pre- and post-contrast, including different contrast trigger levels of 130 and 180 Hounsfield units (HU). BMD was measured using quantitative CT with asynchronous calibration. <em>Results</em>: In 195 participants undergoing cardiac CT (mean age 57±9 years, 37 % females) contrast increased mean thoracic BMD from 116±33 mg/cm<sup>3</sup> (non-enhanced CT) to 130±38 mg/cm<sup>3</sup> (contrast-enhanced CT) (p&lt;0.001). Using clinical cut-off values for very low (&lt;80 mg/cm<sup>3</sup>) and low BMD (&lt;120 mg/cm<sup>3</sup>) showed that 24 % (47/195 participants) were misclassified when BMD was measured on contrast-enhanced CT-scans. Of the misclassified patients, 6 % (12/195 participants) were categorized as having low BMD despite having very low BMD on the non-enhanced images. Contrast-CT using a higher contrast trigger level showed a significant increase in BMD compared to the lower trigger level (119±32 vs. 135±40 mg/cm<sup>3</sup>, p&lt;0.01). <em>Conclusion</em>: For patients undergoing cardiac CT, using contrast-enhanced images to assess BMD entails substantial overestimation. Contrast protocol trigger levels also affect BMD measurements. Adjusting for these factors is needed before contrast-enhanced images can be used clinically. <em>Mini abstract</em>: Osteoporosis is under-diagnosed. Contrast-enhanced CT made to examine other diseases might be utilized simultaneously for bone mineral density (BMD) screening. These scans, however, likely entails overestimation of BMD due to the effect of contrast. Adjusting for this effect is needed before contrast-enhanced images can be implemented clinically for BMD screening.</p></div>","PeriodicalId":50240,"journal":{"name":"Journal of Clinical Densitometry","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Densitometry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1094695023000914","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Osteoporosis is under-diagnosed and often co-exists with other diseases. Very low bone mineral density (BMD) indicates risk of osteoporosis and opportunistic screening for low BMD in CT-scans has been suggested. In a non-contrast enhanced thoracic CT scan, the scan-field-of-view includes vertebrae enabling BMD estimation. However, many CT scans are obtained by administration of contrast material. If the impact of contrast enhancement on BMD measurements could be quantified, considerably more patients are eligible for screening. Methods: This study investigated the impact of intravenous contrast on thoracic BMD measurements in cardiac CT scans pre- and post-contrast, including different contrast trigger levels of 130 and 180 Hounsfield units (HU). BMD was measured using quantitative CT with asynchronous calibration. Results: In 195 participants undergoing cardiac CT (mean age 57±9 years, 37 % females) contrast increased mean thoracic BMD from 116±33 mg/cm3 (non-enhanced CT) to 130±38 mg/cm3 (contrast-enhanced CT) (p<0.001). Using clinical cut-off values for very low (<80 mg/cm3) and low BMD (<120 mg/cm3) showed that 24 % (47/195 participants) were misclassified when BMD was measured on contrast-enhanced CT-scans. Of the misclassified patients, 6 % (12/195 participants) were categorized as having low BMD despite having very low BMD on the non-enhanced images. Contrast-CT using a higher contrast trigger level showed a significant increase in BMD compared to the lower trigger level (119±32 vs. 135±40 mg/cm3, p<0.01). Conclusion: For patients undergoing cardiac CT, using contrast-enhanced images to assess BMD entails substantial overestimation. Contrast protocol trigger levels also affect BMD measurements. Adjusting for these factors is needed before contrast-enhanced images can be used clinically. Mini abstract: Osteoporosis is under-diagnosed. Contrast-enhanced CT made to examine other diseases might be utilized simultaneously for bone mineral density (BMD) screening. These scans, however, likely entails overestimation of BMD due to the effect of contrast. Adjusting for this effect is needed before contrast-enhanced images can be implemented clinically for BMD screening.

心脏CT扫描所得的骨矿物质密度:利用增强扫描进行机会性筛查
骨质疏松症诊断不足,常与其他疾病共存。非常低的骨密度(BMD)表明有骨质疏松症的风险,建议在ct扫描中对低骨密度进行机会性筛查。在非对比增强的胸部CT扫描中,扫描视野包括椎骨,可以估计BMD。然而,许多CT扫描是通过注射造影剂获得的。如果对比增强对骨密度测量的影响可以量化,那么更多的患者有资格进行筛查。本研究探讨了静脉造影剂对心脏CT扫描前后胸椎骨密度测量的影响,包括不同的造影剂触发水平130和180 Hounsfield单位(HU)。采用异步定标定量CT测量骨密度。在195名接受心脏CT的参与者中(平均年龄57±9岁,37%为女性),相比之下,平均胸椎骨密度从116±33 mg/cm3(非增强CT)增加到130±38 mg/cm3(增强CT) (p<0.001)。使用非常低(<80 mg/cm3)和低骨密度(<120 mg/cm3)的临床临界值显示,24%(47/195名参与者)在对比增强ct扫描中测量骨密度时被错误分类。在错误分类的患者中,6%(12/195)被归类为低骨密度,尽管在非增强图像上骨密度非常低。使用较高触发水平的对比ct显示,与较低触发水平相比,骨密度显著增加(119±32 vs 135±40 mg/cm3, p<0.01)。对于接受心脏CT的患者,使用对比增强图像评估骨密度会导致严重的高估。对比协议触发水平也影响BMD测量。在对比增强图像用于临床之前,需要对这些因素进行调整。骨质疏松症的诊断不足。用于检查其他疾病的对比增强CT可同时用于骨密度(BMD)筛查。然而,由于造影剂的影响,这些扫描可能会导致对BMD的高估。在临床应用对比增强图像进行BMD筛查之前,需要对这种效应进行调整。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Densitometry
Journal of Clinical Densitometry 医学-内分泌学与代谢
CiteScore
4.90
自引率
8.00%
发文量
92
审稿时长
90 days
期刊介绍: The Journal is committed to serving ISCD''s mission - the education of heterogenous physician specialties and technologists who are involved in the clinical assessment of skeletal health. The focus of JCD is bone mass measurement, including epidemiology of bone mass, how drugs and diseases alter bone mass, new techniques and quality assurance in bone mass imaging technologies, and bone mass health/economics. Combining high quality research and review articles with sound, practice-oriented advice, JCD meets the diverse diagnostic and management needs of radiologists, endocrinologists, nephrologists, rheumatologists, gynecologists, family physicians, internists, and technologists whose patients require diagnostic clinical densitometry for therapeutic management.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信